These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 6519153
1. Plasma kinetics of dipyrone metabolites in rapid and slow acetylators. Levy M, Flusser D, Zylber-Katz E, Granit L. Eur J Clin Pharmacol; 1984; 27(4):453-8. PubMed ID: 6519153 [Abstract] [Full Text] [Related]
2. Formation and excretion of dipyrone metabolites in man. Zylber-Katz E, Granit L, Levy M. Eur J Clin Pharmacol; 1992; 42(2):187-91. PubMed ID: 1618251 [Abstract] [Full Text] [Related]
3. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators. Levy M, Safadi R, Zylber-Katz E, Granit L, Caraco Y. Eur J Clin Pharmacol; 2001 Sep; 57(6-7):461-5. PubMed ID: 11699610 [Abstract] [Full Text] [Related]
4. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics. Caraco Y, Zylber-Katz E, Granit L, Levy M. Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065 [Abstract] [Full Text] [Related]
5. Plasma protein binding of dipyrone metabolites in man. Zylber-Katz E, Granit L, Levy M. Eur J Clin Pharmacol; 1985 Nov; 29(1):67-71. PubMed ID: 4054207 [Abstract] [Full Text] [Related]
8. Excretion of dipyrone metabolites in human breast milk. Zylber-Katz E, Linder N, Granit L, Levy M. Eur J Clin Pharmacol; 1986 Nov; 30(3):359-61. PubMed ID: 3732376 [Abstract] [Full Text] [Related]
12. Effect of age on the pharmacokinetics of dipyrone. Zylber-Katz E, Granit L, Stessman J, Levy M. Eur J Clin Pharmacol; 1989 Nov; 36(5):513-6. PubMed ID: 2753071 [Abstract] [Full Text] [Related]
13. Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva. Neddermann E, Rohdewald P. Eur J Drug Metab Pharmacokinet; 1988 Nov; 13(2):105-11. PubMed ID: 3208789 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium. Vlahov V, Badian M, Verho M, Bacracheva N. Eur J Clin Pharmacol; 1990 Nov; 38(1):61-5. PubMed ID: 2328750 [Abstract] [Full Text] [Related]
15. [Quantitative thin-layer chromatographic estimation of aminophenazone (I.N.N.), 4-methylaminophenazone and 4-aminophenazone in plasma (author's transl)]. Hüller G, Haustein KO. Pharmazie; 1981 Aug; 36(8):546-8. PubMed ID: 7291286 [Abstract] [Full Text] [Related]
16. High-performance liquid chromatography of dipyrone and its active metabolite in biological fluids. Asmardi G, Jamali F. J Chromatogr; 1983 Oct 14; 277():183-9. PubMed ID: 6643604 [Abstract] [Full Text] [Related]
17. Pharmacokinetics of dipyrone in man; role of the administration route. Asmardi G, Jamali F. Eur J Drug Metab Pharmacokinet; 1985 Oct 14; 10(2):121-5. PubMed ID: 4043141 [Abstract] [Full Text] [Related]
18. Clinical pharmacokinetics of dipyrone and its metabolites. Levy M, Zylber-Katz E, Rosenkranz B. Clin Pharmacokinet; 1995 Mar 14; 28(3):216-34. PubMed ID: 7758252 [Abstract] [Full Text] [Related]
19. High-performance liquid chromatographic assay for metamizol metabolites in rat plasma: application to pharmacokinetic studies. Domínguez-Ramírez AM, Calzadilla PC, Cortés-Arroyo AR, Hurtado Y de la Peña M, López JR, Gómez-Hernández M, López-Muñoz FJ. J Pharm Biomed Anal; 2012 Dec 14; 71():173-8. PubMed ID: 22917546 [Abstract] [Full Text] [Related]
20. Photodegradation study of three dipyrone metabolites in various water systems: identification and toxicity of their photodegradation products. Gómez MJ, Sirtori C, Mezcua M, Fernández-Alba AR, Agüera A. Water Res; 2008 May 14; 42(10-11):2698-706. PubMed ID: 18294672 [Abstract] [Full Text] [Related] Page: [Next] [New Search]